Apfalter P, Blasi F, Boman J, Gaydos C A, Kundi M, Maass M, Makristathis A, Meijer A, Nadrchal R, Persson K, Rotter M L, Tong C Y, Stanek G, Hirschl A M
Department of Clinical Microbiology, Hygiene-Institute, University of Vienna, Vienna, Austria.
J Clin Microbiol. 2001 Feb;39(2):519-24. doi: 10.1128/JCM.39.2.519-524.2001.
The reported rate of detection of Chlamydia pneumoniae DNA within atherosclerotic lesions by PCR varies between 0 and 100%. In this study, identical sets of coded experimental atheroma samples (n = 15) and spiked controls (n = 5) were analyzed by 16 test methods in nine centers by means of PCR. The positive controls were correctly identified to levels of 1, 0.1, and 0.01 inclusion bodies of C. pneumoniae/ml of tissue homogenate by 16 (100%), 11 (69%), and 3 (19%) of the test methods, respectively. Three out of 16 negative controls (19%) were rated positive. Positivity rates for atheroma samples varied between 0 and 60% for the different test methods, with the maximum concordant result for positivity being only 25% for one carotid artery sample. There was no consistent pattern of positive results among the various laboratories, and there was no correlation between the detection rates and the sensitivity of the assay used.
通过聚合酶链反应(PCR)检测动脉粥样硬化病变中肺炎衣原体DNA的报告率在0%至100%之间。在本研究中,九个中心采用PCR方法,通过16种检测方法对相同的一组编码实验性动脉粥样硬化样本(n = 15)和加标对照(n = 5)进行了分析。阳性对照在组织匀浆中肺炎衣原体/ml分别为1、0.1和0.01个包涵体水平时,分别有16种(100%)、11种(69%)和3种(19%)检测方法正确识别。16个阴性对照中有3个(19%)被判定为阳性。不同检测方法的动脉粥样硬化样本阳性率在0%至60%之间,其中一个颈动脉样本的阳性最大一致率仅为25%。各实验室之间没有一致的阳性结果模式,检测率与所用检测方法的灵敏度之间也没有相关性。